1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > World Synthetic Biology Market - Opportunities and Forecast, 2014 - 2020

Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist in nature. An impending need to understand the functioning of genetic elements, cells and biological processes has led to the emergence of synthetic biology. Synthetic biology products are used across many industries, including pharmaceutical & diagnostics, energy, bioplastics and environment.World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in the market.Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA regions. In 2015, Europe was the leading geography in terms of revenue generation followed by North America. Further, Europe would continue to maintain its lead position through 2020 owing to constant support from European government and private organizations, establishment of small start-ups and investment by leading companies especially in the biofuel segment. Asia Pacific is projected as the fastest growing market owing to increasing number of research entities.The report provides a comprehensive analysis of the leading companies operating in the world synthetic biology market. Key companies profiled in the report are Thermo Fischer Scientific, GenScript, DNA2.0, Integrated DNA technologies, Eurofins Scientific, Inc., Origene technologies, Scientific genomics Inc. Editas Medicine, Inc., Pareto Biotechnologies, Blue heron, TeselaGen, Twist biosciences, Syntrox Inc., and others.Key BenefitsThis report provides an extensive analysis of the current and emerging market trends and dynamics in the world synthetic biology market.The report provides a detailed analysis of the current market and estimations during 20142020, which would enable the stakeholders to capitalize on the prevailing market opportunities.The synthetic biology market scenario has been comprehensively analyzed in accordance to key geographical regions.The key market players operating in the market have been profiled in the report, and their strategies have been thoroughly analyzed to understand the competitive outlook of the market.Competitive intelligence highlights the business practices followed by leading market players across geographies.SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

KEY MARKET SEGMENTS
:The world Synthetic Biology market is segmented as:By ProductsSynthetic DNASynthetic oligosSynthetic genesSoftware toolsChassis organismsSynthetic clonesSynthetic cellsBy TechnologyNucleotide synthesis and sequencingBioinformaticsMicrofluidicsGenetic engineeringBy ApplicationPharmaceuticals and diagnosticsChemicalsBiofuelsBioplasticsOthers (Environment, agriculture & aquaculture)By GeographyNorth AmericaEuropeAsia PacificLAMEA

Table Of Contents

World Synthetic Biology Market - Opportunities and Forecast, 2014 - 2020
CHAPTER 1 INTRODUCTION1.1 Report description1.2 Key benefits1.3 Key market segments1.4 Research methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1 CXO perspective2.2 Market beyond: what to expect by 20252.2.1 Moderate growth scenario2.2.2 Rapid growth scenario2.2.3 Diminishing growth scenarioCHAPTER 3 MARKET OVERVIEW3.1 Market definition and scope3.2 Key findings3.2.1 Top impacting factors3.2.2 Top investment pockets3.2.3 Top winning strategies3.3 Porters five force analysis3.3.1 Fewer suppliers lead to higher bargaining power of suppliers3.3.2 Higher buyer concentration leads to low bargaining power3.3.3 Low threat of substitutes due to lack of superior alternatives3.3.4 Low threat of new entrants due to high capital investment3.3.5 Moderate competitive rivalry3.4 Value chain analysis3.4.1 Research and product development3.4.2 Product testing3.4.3 Manufacturing3.4.4 End users3.5 Regulatory norms3.6 Concerns related to synthetic biology3.7 Market Dynamics3.7.1 Drivers3.7.1.1 Funding from government and Private organizations3.7.1.2 Rising number of research facilities3.7.1.3 Rising count of new entrants3.7.1.4 Declining cost of DNA Sequencing3.7.2 Restraints3.7.2.1 Bio-safety and Bio-security Issues3.7.2.2 Ethical concerns and stringent regulations3.7.3 Opportunities3.7.3.1 growing demand of bio-fuels and Bioplastics3.7.3.2 increasing research activities in Asia Pacific region3.7.3.3 rising Randamp;D investmentsCHAPTER 4 OVERVIEW OF NUCLEOTIDE SYNTHESIS4.1 Technological trends in nucleotide synthesis4.2 Commercial application scope for large DNA constructs in Europe and North America4.2.1 Antibody engineering4.2.2 Metabolic engineering4.2.3 Pathway engineering4.2.4 Other potential application4.3 Top players positioning, 2014, (Focus on nucleotide synthesis)4.4 Market dynamics specific to nucleotide synthesis4.4.1 Drivers4.4.1.1 Technical advancements in integrated sequencing4.4.1.2 Growing demand for large DNA constructs4.4.1.3 Increasing accountability of government funding4.4.2 Restraints4.4.2.1 High cost and longer duration of nucleotide synthesis4.4.2.2 Absence of regulatory guidelines4.4.3 Opportunities4.4.3.1 Exploring opportunities in European countriesCHAPTER 5 WORLD SYNTHETIC BIOLOGY MARKET, BY PRODUCT5.1 Overview5.1.1 Market size and forecast5.2 Synthetic DNA5.2.1 Key market trends5.2.2 Key growth factors and opportunities5.2.3 Market size and forecast5.3 Synthetic Oligonucleotides5.3.1 Key market trends5.3.2 Key growth factors and opportunities5.3.3 Market size and forecast5.4 Synthetic Genes5.4.1 Key market trends5.4.2 Key growth factors and opportunities5.4.3 Market size and forecast5.5 Software tools5.5.1 Key market trends5.5.2 Key growth factors and opportunities5.5.3 Market size and forecast5.6 Chassis Organisms5.6.1 Key market trends5.6.2 Key growth factors and opportunities5.6.3 Market size and forecast5.7 Synthetic Clones5.7.1 Key market trends5.7.2 Key growth factors and opportunities5.7.3 Market size and forecast5.8 Synthetic cells5.8.1 Key market trends5.8.2 Key growth factors and opportunities5.8.3 Market size and forecastCHAPTER 6 WORLD SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY6.1 Overview6.1.1 Market size and forecast6.2 Nucleotide synthesis and sequencing6.2.1 Key market trends6.2.2 Key growth factors and opportunities6.2.3 Market size and forecast6.3 Bioinformatics technologies6.3.1 Key market trends6.3.2 Key growth factors and opportunities6.3.3 Market size and forecast6.4 Microfluidics technologies6.4.1 Key market trends6.4.2 Key growth factors and opportunities6.4.3 Market size and forecast6.5 Genetic engineering6.5.1 Key market trends6.5.2 Key growth factors and opportunities6.5.3 Market size and forecastCHAPTER 7 WORLD SYNTHETIC BIOLOGY MARKET, BY APPLICATION7.1 Overview7.1.1 Market size and forecast7.2 Pharmaceuticals andamp; diagnostics7.2.1 Key market trends7.2.2 Key growth factors and opportunities7.2.3 Market size and forecast7.3 Biofuels7.3.1 Key market trends7.3.2 Key growth factors and opportunities7.3.3 Market size and forecast7.4 Chemicals7.4.1 Key market trends7.4.2 Key growth factors and opportunities7.4.3 Market size and forecast7.5 Bioplastics7.5.1 Key market trends7.5.2 Key growth factors and opportunities7.5.3 Market size and forecast7.6 Others (agriculture, bioremediation and aquaculture)7.6.1 Market size and forecastCHAPTER 8 WORLD SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY8.1 Overview8.1.1 Market size and forecast8.2 North America8.2.1 Key market trends8.2.2 Key growth factors and opportunities8.2.3 Market size and forecast8.3 Europe8.3.1 Key market trends8.3.2 Key growth factors and opportunities8.3.3 Market size and forecast8.4 Asia Pacific8.4.1 Key market trends8.4.2 Key growth factors and opportunities8.4.3 Market size and forecast8.5 LAMEA8.5.1 Key market trends8.5.2 Key growth factors and opportunities8.5.3 Market size and forecastCHAPTER 9 COMPANY PROFILES9.1 GEN9 Inc.9.1.1 Company overview9.1.2 Company snapshot9.1.3 Strategic moves and developments9.1.4 SWOT analysis of Gen9 Inc.9.2 Codexis Inc.9.2.1 Company overview9.2.2 Company snapshot9.2.3 Business performance9.2.4 Strategic moves and developments9.2.5 SWOT analysis of Codexis9.3 OriGene Technologies, Inc.9.3.1 Company overview9.3.2 Company snapshot9.3.3 Strategic moves and developments9.3.4 SWOT analysis of OriGene9.4 Synthetic Genomics, Inc.9.4.1 Company overview9.4.2 Company snapshot9.4.3 Strategic moves and developments9.4.4 SWOT analysis of Synthetic Genomics9.5 Thermo fisher Scientific9.5.1 Company overview9.5.2 Company snapshot9.5.3 Business performance9.5.4 Strategic moves and developments9.5.5 SWOT analysis of Thermo fisher Scientific9.6 GENEWIZ, Inc.9.6.1 Company overview9.6.2 Company snapshot9.6.3 Strategic moves and development9.6.4 SWOT analysis of GENEWIZ, Inc.9.7 Eurofins Scientific, Inc.9.7.1 Company overview9.7.2 Company snapshot9.7.3 Services portfolio9.7.4 Strategic moves and developments9.7.5 Business performance9.7.6 SWOT analysis of Eurofins Scientific, Inc.9.8 Integrated DNA Technologies, Inc.9.8.1 Company overview9.8.2 Company snapshot9.8.3 Services Portfolio9.8.4 Strategic moves and development9.8.5 SWOT analysis of Integrated DNA Technologies, Inc.9.9 DNA2.0, Inc.9.9.1 Company overview9.9.2 Company snapshot9.9.3 Services portfolio9.9.4 Strategic moves and development9.9.5 SWOT analysis of DNA2.0, Inc.9.10 Pareto Biotechnologies9.10.1 Company overview9.10.2 Company snapshot9.10.3 Services Portfolio9.10.4 Strategic moves and development9.10.5 SWOT analysis of Pareto Biotechnologies9.11 Synthorx, Inc.9.11.1 Company overview9.11.2 Company snapshot9.11.3 Services portfolio9.11.4 SWOT analysis of Synthorx, Inc.9.12 TeselaGen Biotechnology9.12.1 Company overview9.12.2 Company snapshot9.12.3 Services portfolio9.12.4 Strategic moves and developments9.12.5 SWOT Analysis of TeselaGen Biotechnology.9.13 Editas Medicine, Inc.9.13.1 Company overview9.13.2 Company snapshot9.13.3 Services portfolio9.13.4 Strategic moves and development9.13.5 SWOT analysis of Editas Medicine, Inc.9.14 GenScript Corporation9.14.1 Company overview9.14.2 Company snapshot9.14.3 Strategic moves and developments9.14.4 SWOT analysis of GenScript9.15 Twist Bioscience9.15.1 Company overview9.15.2 Company snapshot9.15.3 Services portfolio9.15.4 Strategic moves and developments9.15.5 SWOT analysis of Twist Bioscience9.16 GeneWorks Pty Ltd.9.16.1 Company overview9.16.2 Company snapshot9.16.3 Services portfolio9.16.4 SWOT analysis of GeneWorks Pty. Ltd.9.17 Proterro, Inc.9.17.1 Company overview9.17.2 Company snapshot9.17.3 Services portfolio9.17.4 Strategic moves and developments9.17.5 SWOT analysis of Proterro, Inc.9.18 Blue heron (OriGene technologies Inc.)9.18.1 Company overview9.18.2 Company snapshot9.18.3 Service portfolio of Blue heron (OriGene technologies Inc.)9.18.4 SWOT analysis of Blue heron (OriGene technologies Inc.)List of FiguresFIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020 - 2025)FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020 - 2025)FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020 - 2025)FIG. 4 TOP IMPACTING FACTORS (2014-2020)FIG. 5 TOP INVESTMENT POCKETSFIG. 6 TOP WINNING STRATEGIES (2013-2015)FIG. 7 PORTERS FIVE FORCE ANALYSISFIG. 8 VALUE CHAIN ANALYSISFIG. 9 PLAYER POSITIONING OF SYNTHETIC BIOLOGY MARKET (2013)FIG. 10 BIOFUEL PRODUCTION BY MAJOR REGIONS (2011 2020)FIG. 11 SWOT ANALYSIS OF GEN9, INC.FIG. 12 REVENUE GENERATED BY CODEXIS, INC., (2014-2020)FIG. 13 SWOT ANALYSIS OF CODEXISFIG. 14 SWOT ANALYSIS OF ORIGENE TECHNOLOGIES, INC.FIG. 15 SWOT ANALYSIS OF SYNTHETIC GENOMICSFIG. 16 REVENUE GENERATED BY THERMO FISHER SCIENTIFIC (2012-2014)FIG. 17 SWOT ANALYSIS OF THERMOFISHER SCIENTIFICFIG. 18 SWOT ANALYSIS OF GENEWIZ, INC.FIG. 19 REVENUE GENERATED BY EUROFINS SCIENTIFIC (2012-2014)FIG. 20 SWOT ANALYSIS OF EUROFINS SCIENTIFIC, INC.FIG. 21 SWOT ANALYSIS OF INTEGRATED DNA TECHNOLOGIES, INC.FIG. 22 SWOT ANALYSIS OF DNA2.0, INC.FIG. 23 SWOT ANALYSIS OF PARENTO BIOTECHNOLOGIESFIG. 24 SWOT ANALYSIS OF SYNTHORX, INC.FIG. 25 SWOT ANALYSIS OF TESELAGEN BIOTECHNOLOGY.FIG. 26 SWOT ANALYSIS OF EDITAS MEDICINE, INC.FIG. 27 SWOT ANALYSIS OF GENSCRIPTFIG. 28 SWOT ANALYSIS OF TWIST BIOSCIENCEFIG. 29 SWOT ANALYSIS OF GENEWORKS PTT. LTD.FIG. 30 SWOT ANALYSIS OF PROTERRO, INC.FIG. 31 SWOT ANALYSIS OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)List of TablesTABLE 1 WORLD SYNTHETIC BIOLOGY MARKET, MODERATE GROWTH SCENARIO, VALUE, 2020 2025 ($MILLION)TABLE 2 WORLD SYNTHETIC BIOLOGY MARKET RAPID GROWTH SCENARIO, VALUE, 2020 2025 ($MILLION)TABLE 3 WORLD SYNTHETIC BIOLOGY MARKET, DIMINISHING GROWTH SCENARIO, VALUE, 2020 2025 ($MILLION)TABLE 4 COMMERCIAL APPLICATION OF SYNTHETIC BIOLOGY IN DERIVING RENEWABLE ENERGYTABLE 5 WORLD SYNTHETIC BIOLOGY MARKET REVENUE, BY PRODUCT, 2014 2020 ($MILLION)TABLE 6 WORLD SYNTHETIC DNA MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 7 WORLD SYNTHETIC OLIGONUCLEOTIDES MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 8 WORLD SYNTHETIC GENES MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 9 SOFTWARE TOOLS DEVELOPED FOR THE MODELING AND SIMULATION OF BIOLOGICAL INTERACTIONSTABLE 10 WORLD SYNTHETIC BIOLOGY SOFTWARE TOOLS MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 11 WORLD CHASSIS ORGANISMS MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 12 WORLD SYNTHETIC CLONES MARKET REVENUE, BY GEOGRAPHY,2014 2020 ($MILLION)TABLE 13 WORLD SYNTHETIC CELLS MARKET REVENUE BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 14 WORLD SYNTHETIC BIOLOGY MARKET REVENUE BY TECHNOLOGY, 2014 2020 ($MILLION)TABLE 15 WORLD NUCLEOTIDE SYNTHESIS AND SEQUENCING MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 16 WORLD SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 17 WORLD SYNTHETIC BIOLOGY MICROFLUIDICS TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 18 WORLD GENETIC ENGINEERING MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 19 WORLD SYNTHETIC BIOLOGY MARKET REVENUE, BY APPLICATION, 2014 2020 ($MILLION)TABLE 20 SYNTHETIC BIOLOGY PHARMACEUTICALS andamp; DIAGNOSTICS APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 21 SYNTHETIC BIOLOGY BIOFUELS INDUSTRY APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 22 SYNTHETIC BIOLOGY CHEMICAL INDUSTRY APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 23 SYNTHETIC BIOLOGY BIOPLSATICS INDUSTRY APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 24 SYNTHETIC BIOLOGY OTHER APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2014 2020 ($MILLION)TABLE 25 NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE, BY TECHNOLOGY, 2014 - 2020 ($MILLION)TABLE 26 EUROPE SYNTHETIC BIOLOGY MARKET REVENUE, BY TECHNOLOGY, 2014 - 2020 ($MILLION)TABLE 27 ASIA PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE, BY APPLICATION, 2014 - 2020 ($MILLION)TABLE 28 LAMEA SYNTHETIC BIOLOGY MARKET REVENUE, BY TECHNOLOGY, 2014 - 2020 ($MILLION)TABLE 29 GEN9 INC., SNAPSHOTTABLE 30 CODEXIS SNAPSHOTTABLE 31 ORIGENE SNAPSHOTTABLE 32 SYNTHETIC GENOMICS SNAPSHOTTABLE 33 COMPANY SNAPSHOT OF THERMO FISHER SCIENTIFICTABLE 34 COMPANY SNAPSHOTTABLE 35 EUROFINS SCIENTIFIC, INC. SNAPSHOTTABLE 36 SERVICE PORTFOLIO OF EUROFINS SCIENTIFIC, INC.TABLE 37 COMPANY SNAPSHOT OF INTEGRATED DNA TECHNOLOGIES, INCTABLE 38 SERVICES PORTFOLIO OF INTEGRATED DNA TECHNOLOGIES, INC.TABLE 39 COMPANY SNAPSHOT OF DNA2.0, INC.TABLE 40 SERVICES PORTFOLIO OF DNA2.0, INC.TABLE 41 COMPANY SNAPSHOT OF PARENTO BIOTECHNOLOGIESTABLE 42 SERVICES PORTFOLIO OF PARENTO BIOTECHNOLOGIESTABLE 43 COMPANY SNAPSHOT OF SYNTHORX, INC.TABLE 44 SERVICES PORTFOLIO OF SYNTHORX, INC.TABLE 45 COMPANY SNAPSHOT OF TESELAGEN BIOTECHNOLOGYTABLE 46 SERVICES PORTFOLIO OF TESELAGEN BIOTECHNOLOGYTABLE 47 COMPANY SNAPSHOT OF EDITAS MEDICINE, INC.TABLE 48 SERVICES PORTFOLIO OF EDITAS MEDICINE, INC.TABLE 49 GENSCRIPT SNAPSHOTTABLE 50 COMPANY SNAPSHOT OF TWIST BIOSCIENCETABLE 51 SERVICES PORTFOLIO OF TWIST BIOSCIENCETABLE 52 COMPANY SNAPSHOT OF GENEWORKS PTY. LTD.TABLE 53 SERVICES PORTFOLIO OF GENEWORKS PTY. LTD.TABLE 54 COMPANY SNAPSHOT OF PROTERRO, INC.TABLE 55 SERVICES PORTFOLIO OF PROTERRO, INC.TABLE 56 COMPANY SNAPSHOT OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)TABLE 57 SERVICE PORTFOLIO OF BLUE HERON (ORIGENE TECHNOLOGIES INC.)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
In situ Hybridization Market by Technique, Application, & End User - Global Forecast to 2021

In situ Hybridization Market by Technique, Application, & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing ...

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use And Segment Forecasts, 2014 - 2025

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The Clustered regularly interspaced short palindromic repeats CRISPR and CRISPR-associated (Cas) genes market is anticipated to reach USD 4.09 billion by 2025, according to a new report by Grand View Research, ...

Global Human Identification Market - Growth, Trends & Forecasts (2017 - 2022)

Global Human Identification Market - Growth, Trends & Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The Global Human Identification market is poised to reach $XX million by the end of 2020. The CAGR is estimated to be XX%. The most recent technology being used in the Human Identification market is the ...


Download Unlimited Documents from Trusted Public Sources

DNA Industry in the US

  • March 2017
    13 pages
  • DNA  

  • United States  

View report >

Encephalitis Statistics in Japan and China

  • March 2017
    7 pages
  • Encephalitis  

  • Japan  

    China  

View report >

Genetic Industry in Africa

  • March 2017
    12 pages
  • Genetic  

  • Africa  

    United States  

View report >

Genomics Statistics

11 days ago

Related Market Segments :

DNA
Nucleotide
Synthetic Biology

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.